Teva Sells Off Remaining Women's Health Assets For $1.4B
By Matthew Guarnaccia ( September 18, 2017, 6:43 PM EDT) -- Teva Pharmaceutical Industries Ltd. said Monday it will sell the remainder of its global women's health portfolio in a pair of transactions totaling nearly $1.4 billion as the company turns its focus toward central nervous system and respiratory medicines....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.